• Merck & Co. Inc., of Whitehouse Station, N.J., said the District Court for the District of New Jersey ruled in its favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc., of Pittsburgh, upholding Merck's patent on Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin).